1. Home
  2. WETH vs HBIO Comparison

WETH vs HBIO Comparison

Compare WETH & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WETH

Wetouch Technology Inc.

HOLD

Current Price

$1.36

Market Cap

21.1M

Sector

N/A

ML Signal

HOLD

Logo Harvard Bioscience Inc.

HBIO

Harvard Bioscience Inc.

HOLD

Current Price

$6.30

Market Cap

24.9M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
WETH
HBIO
Founded
1992
1901
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
21.1M
24.9M
IPO Year
2020
2000

Fundamental Metrics

Financial Performance
Metric
WETH
HBIO
Price
$1.36
$6.30
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$18.00
AVG Volume (30 Days)
126.6K
26.1K
Earning Date
04-13-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
15.38
N/A
EPS
0.32
N/A
Revenue
$45,136,818.00
$116,176,000.00
Revenue This Year
N/A
$4.77
Revenue Next Year
N/A
$8.55
P/E Ratio
$4.28
N/A
Revenue Growth
6.76
N/A
52 Week Low
$0.78
$0.38
52 Week High
$3.68
$7.50

Technical Indicators

Market Signals
Indicator
WETH
HBIO
Relative Strength Index (RSI) 35.70 53.07
Support Level $1.26 $6.05
Resistance Level $1.46 $7.00
Average True Range (ATR) 0.16 0.44
MACD -0.02 0.05
Stochastic Oscillator 6.25 67.58

Price Performance

Historical Comparison
WETH
HBIO

About WETH Wetouch Technology Inc.

Wetouch Technology Inc is a touch panel supplier focused on R&D, production, and sales of touch screen products. It offers touchscreens for a variety of applications, including GPS/car entertainment panels for the automotive industry, industrial human-machine interface, financial and banking terminals, point of sale, lottery and gaming machines, smart home, robots, and charging stations. The company sells touchscreen products both domestically in China and internationally. The company generates the majority of its revenue from the PRC, followed by the Republic of China and Korea.

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.

Share on Social Networks: